Harpoon Therapeutics Inc expected to post a loss of 56 cents a share - Earnings Preview

Harpoon Therapeutics

04/11/2022 11:05

* Harpoon Therapeutics Inc  HARP.OQ   HARP.O  is expected
to show
a rise in quarterly revenue when it reports  results on November
8 (estimated). 
    * The South San Francisco California-based  company is
expected to
report  a 24.1% increase in revenue to $5.563 million from $4.48
million a year ago, according to the mean estimate from 8
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Harpoon
Therapeutics Inc
is for a loss of 56 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 9 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Harpoon
Therapeutics Inc is $7​, above​ its last closing price of $0.86.
​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2022  -0.61       -0.56      -0.53     Beat    6.1
 Mar. 31 2022  -0.59       -0.55      -0.62     Missed  -13.7
 Dec. 31 2021  -0.43       -0.42      -0.66     Missed  -55.7​
 Sep. 30 2021  -0.53       -0.52      -0.51     Beat    1.5
 ​​Jun.        -0.41       -0.43      -0.52     Missed  -19.7
 30 2021                                                
 Mar. 31 2021  -0.42       -0.44      -0.37     Beat    16​
 Dec. 31 2020  -0.48       -0.54      -0.45     Beat    16.7
 Sep. 30 2020  -0.47       -0.50      -0.53     Missed  -7
 This summary was machine generated November 4 at 11:05 GMT.  All
figures in US dollars  unless otherwise stated